ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO1175

Graft Survival in Different Kidney Allograft Rejection Phenotypes: An Analysis of 2,166 Biopsies

Session Information

Category: Transplantation

  • 2002 Transplantation: Clinical

Authors

  • Santithanmakorn, Chayanan, King Chulalongkorn Memorial Hospital, Bangkok, Thailand
  • Udomkarnjananun, Suwasin, King Chulalongkorn Memorial Hospital, Bangkok, Thailand
Background

Acute rejection remains a major cause of graft loss after kidney transplantation, yet the long-term impact of distinct rejection phenotypes and histopathologic lesions is incompletely defined.

Methods

We conducted a retrospective cohort study of 747 kidney transplant recipients at King Chulalongkorn Memorial Hospital (2010–2024), including 2,166 allograft biopsies. Rejection phenotypes and Banff lesion scores were modeled as time-varying covariates. Graft failure was analyzed using competing-risk regression with death as a competing event. Principal component analysis (PCA) was used to identify dominant patterns of histologic injury.

Results

Rejection was associated with a higher risk of graft failure, with substantial heterogeneity across phenotypes. At 5 years, graft failure incidence was 3.0% without rejection, compared with 7.6% in borderline TCMR, 17.1% in acute TCMR, 15.9% in active ABMR, and 54.3% in chronic active TCMR. At 10 years, graft failure increased to 9.3%, 22.1%, 44.9%, 42.2%, and 91.7%, respectively, with similarly poor outcomes in mixed rejection (72.3%). Increasing severity of key Banff lesions (g, ptc, i, t) was independently associated with graft failure. PCA identified three major injury patterns—tubulointerstitial inflammation, microvascular inflammation, and chronic injury—all of which were associated with graft failure and demonstrated improved discrimination compared with conventional Banff-based classification.

Conclusion

Rejection phenotypes confer markedly different long-term risks of graft failure, with the worst outcomes observed in chronic active TCMR and mixed rejection. Integrating time-varying histopathologic data with composite injury patterns may enhance risk stratification and inform long-term management in kidney transplant recipients.

Evolution and dynamic transition of rejection phenotypes over time.